Kiirya Yerusa, Musoke Philippa, Adobea Odei Obeng-Amoako Gloria, Kalyango Joan
Makerere University School of Medicine Clinical Epidemiology Unit Uganda, Uganda.
Makerere University, Department of Paediatrics and Child Health, Uganda.
Public Health Pract (Oxf). 2021 Jan 26;2:100085. doi: 10.1016/j.puhip.2021.100085. eCollection 2021 Nov.
Option-B+ programs in Uganda have reported high levels of loss to follow up (LTFU) after cessation of breastfeeding, and this remains unknown beyond this period. In this study, we assessed the incidence and factors associated with LTFU two to four years after delivery among Option-B+ mothers.
Retrospective cohort
We reviewed files of 452 mothers who enrolled on Option-B+ between January 1st, 2013 and December 31st, 2014 at Kisenyi Health Centre IV in Kampala district. We assessed factors associated with LTFU using Cox proportional hazards regression. We also explored the reasons for LTFU using three focus group discussions, five in-depth and three key informant interviews.
Of the 452 mothers, 131(29%) were LTFU after delivery. The incidence of LTFU after delivery was 17/1000 person months (95% CI, 14-30/1000) with a median follow up of 32 months. The risk of LTFU was higher among mothers who started ART on the day they tested HIV positive (aHR = 1.66, 95% CI; 1.25-2.20, p-value< 0.001). Reasons for LFTU included transport costs, stigma, poor human resource policies and non-disclosure.
LTFU after delivery among Option-B+ mothers is higher than the global target of 15%. ART initiation on the day a mother tests positive increases the risk of LTFU. The major reasons for LTFU were stigma and non-disclosure. To reduce the risk of LTFU, we recommend approaches that encourage disclosure to sexual partners and ongoing specific support to mothers who are initiated on ART-the day of positive test.
乌干达的“B+方案”项目报告称,停止母乳喂养后失访(LTFU)率很高,而在此之后的情况仍不明确。在本研究中,我们评估了“B+方案”母亲产后两到四年失访的发生率及相关因素。
回顾性队列研究
我们查阅了2013年1月1日至2014年12月31日期间在坎帕拉区基森伊第四健康中心登记参加“B+方案”的452名母亲的档案。我们使用Cox比例风险回归评估与失访相关的因素。我们还通过三次焦点小组讨论、五次深入访谈和三次关键 informant访谈探讨了失访的原因。
在452名母亲中,131名(29%)产后失访。产后失访的发生率为17/1000人月(95%CI,14 - 30/1000),中位随访时间为32个月。在检测出HIV阳性当天开始接受抗逆转录病毒治疗(ART)的母亲中,失访风险更高(调整后风险比[aHR]=1.66,95%CI;1.25 - 2.20,p值<0.001)。失访原因包括交通成本、耻辱感、不良的人力资源政策和未披露信息。
“B+方案”母亲产后失访率高于15%的全球目标。母亲检测呈阳性当天开始接受ART会增加失访风险。失访的主要原因是耻辱感和未披露信息。为降低失访风险,我们建议采取鼓励向性伴侣披露信息的方法,并对检测呈阳性当天开始接受ART的母亲持续提供特定支持。